Revista Espanola de Cardiologia Suplementos最新文献_第4页

Coordinación de unidades de rehabilitación cardiaca hospitalaria con atención primaria. Incentivando la creación de unidades comunitarias 医院心脏康复单位与初级保健的协调。鼓励建立社区单位

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30019-4

Raquel Campuzano , Carolina de Tiedra

引用次数: 0

Fibrilación auricular y cardiopatía isquémica: más allá de la prevención del ictus 房颤与缺血性心脏病:超越中风预防

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30012-1

Eduardo Alegría Ezquerra , Rosa Agra Bermejo , Luis Javier Alonso Perez , Miguel Ángel Fernández Fernández , Jose Manuel Vázquez Rodríguez , Óscar Díaz Castro , Marisol Bravo Amaro , Ramón Ríos Vázquez , Julio Martí-Almor

{"title":"Fibrilación auricular y cardiopatía isquémica: más allá de la prevención del ictus","authors":"Eduardo Alegría Ezquerra , Rosa Agra Bermejo , Luis Javier Alonso Perez , Miguel Ángel Fernández Fernández , Jose Manuel Vázquez Rodríguez , Óscar Díaz Castro , Marisol Bravo Amaro , Ramón Ríos Vázquez , Julio Martí-Almor","doi":"10.1016/S1131-3587(20)30012-1","DOIUrl":"10.1016/S1131-3587(20)30012-1","url":null,"abstract":"<div><p>The main aim of management in patients with atrial fibrillation is to reduce the risk of stroke using appropriate antithrombotic treatment. However, despite adequate anticoagulation, there remains a substantial residual risk of ischemic events, particularly myocardial infarction and cardiovascular death. A more general approach is needed. Consequently, in patients with atrial fibrillation, anticoagulation treatment should seek to achieve the twin targets of reducing the risk of both stroke and ischemic events. Studies have demonstrated that vitamin K antagonists reduce the risk of stroke and ischemic events only when anticoagulation control is optimal, a situation that occurs in only a small number of patients. Direct oral anticoagulants are generally more effective and safer than vitamin K antagonists. However, not all direct oral anticoagulants appear to offer the same protection against ischemic events. It has been shown that rivaroxaban significantly reduces the risk of myocardial infarction (by 18%). In fact, studies demonstrate that rivaroxaban provides comprehensive vascular protection across a range of clinical scenarios, not only in patients with atrial fibrillation, but also in those with atherosclerotic vascular disease.</p></div>","PeriodicalId":34926,"journal":{"name":"Revista Espanola de Cardiologia Suplementos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56636141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Consenso de expertos en la coordinación de la rehabilitación cardiaca entre cardiología y atención primaria. Proyecto RehaCtivAP 关于协调心脏病学和初级保健之间心脏康复的专家共识。RehaCtivAP项目

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30020-0

Vicente Arrarte , Raquel Campuzano , Carolina de Tiedra , Teresa Manjón , José Antonio Alarcón , Rosa Fernández , Alberto Calderón , Almudena Castro , Alfonso Valle , Oona Meroño , Juan Carlos Obaya , Mercedes Lasa

{"title":"Consenso de expertos en la coordinación de la rehabilitación cardiaca entre cardiología y atención primaria. Proyecto RehaCtivAP","authors":"Vicente Arrarte , Raquel Campuzano , Carolina de Tiedra , Teresa Manjón , José Antonio Alarcón , Rosa Fernández , Alberto Calderón , Almudena Castro , Alfonso Valle , Oona Meroño , Juan Carlos Obaya , Mercedes Lasa","doi":"10.1016/S1131-3587(20)30020-0","DOIUrl":"10.1016/S1131-3587(20)30020-0","url":null,"abstract":"<div><p>Cardiac rehabilitation is an essential part of continuing care for patients who have experienced an acute coronary syndrome. Moreover, a patient-centered approach requires the coordination of cardiology care and primary care in order to improve adherence to rehabilitation programs and to ensure appropriate continuing care. Community cardiac rehabilitation programs are essential for achieving the objectives of disease prevention. However, implementation may be difficult and program managers and specialists may need support. It is important to raise awareness of the need to support specialists who have taken the initiative in creating these programs. The aim of this paper was to summarize the basic elements of care and of the coordination between cardiology departments and primary care needed to create and develop community cardiac rehabilitation programs.</p></div>","PeriodicalId":34926,"journal":{"name":"Revista Espanola de Cardiologia Suplementos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1131-3587(20)30020-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56636333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Posicionamientos de la Sociedad Española de Cardiología sobre procesos y procedimientos cardiológicos en la pandemia de COVID-19 西班牙心脏病学会对COVID-19大流行中的心脏病过程和程序的立场

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30030-3

Eduardo Díaz Molina , Rafael Vidal-Pérezb , Héctor Bueno

引用次数: 1

Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones covid - 19患者的药物治疗:相互作用和适应症

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30033-9

Mercedes Iglesias , Eva Benavent , Óscar Murillo , José Luis Ferreiro

引用次数: 2

El tratamiento de la dislipemia: una historia de objetivos cumplidos y retos apasionantes 血脂异常的治疗:实现目标和令人兴奋的挑战的历史

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30022-4

José Tuñón

引用次数: 0

Selección del tratamiento anticoagulante óptimo para el paciente con fibrilación auricular y diabetes o enfermedad renal crónica: papel del rivaroxabán 心房颤动与糖尿病或慢性肾病患者抗凝治疗的最佳选择:利伐沙班的作用

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30015-7

José María Cepeda , Vicente Ignacio Arrarte Esteban , Lorenzo Facila Rubio , Vicente Giner Galvañ , Jose Luis Górriz , Javier Trujillo Santos , Juan José Tamarit Garcia

{"title":"Selección del tratamiento anticoagulante óptimo para el paciente con fibrilación auricular y diabetes o enfermedad renal crónica: papel del rivaroxabán","authors":"José María Cepeda , Vicente Ignacio Arrarte Esteban , Lorenzo Facila Rubio , Vicente Giner Galvañ , Jose Luis Górriz , Javier Trujillo Santos , Juan José Tamarit Garcia","doi":"10.1016/S1131-3587(20)30015-7","DOIUrl":"10.1016/S1131-3587(20)30015-7","url":null,"abstract":"<div><p>Both diabetes mellitus and chronic kidney disease increase the risk of atrial fibrillation. In turn, the coexistence of diabetes and chronic kidney disease synergistically increases the thromboembolic risk associated with atrial fibrillation, which puts affected patients at a particularly high risk and makes it necessary to focus treatment not only on reducing the risk of embolism but also on providing more general prophylaxis. Although all oral anticoagulants are effective in reducing the risk of stroke in diabetic patients with atrial fibrillation, there are indications that rivaroxaban could also reduce cardiovascular mortality in this population, thereby providing additional benefits. Moreover, it has been reported that renal function deteriorates on vitamin K antagonist treatment (i.e. warfarin-related nephropathy). Consequently, the ideal anticoagulant treatment would decrease the risk of thromboembolic complications without also being associated with impaired renal function. In this context, it appears that some direct oral anticoagulants, such as dabigatran and rivaroxaban, may have a lower risk of adverse renal events than warfarin.</p></div>","PeriodicalId":34926,"journal":{"name":"Revista Espanola de Cardiologia Suplementos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1131-3587(20)30015-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56635802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Análisis de la protección global del paciente con fibrilación auricular con rivaroxabán 利伐沙班对房颤患者的整体保护分析

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30010-8

Carlos Escobar , Vivencio Barrios

引用次数: 0

Complicaciones cardiovasculares y pronóstico en pacientes con COVID-19 COVID-19患者心血管并发症及预后

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30029-7

Alberto Cordero , David Escribano , Vicente Bertomeu-González

引用次数: 2

Reorganización de la actividad asistencial ambulatoria en la era de la COVID-19. La hora de la e-consulta COVID-19时代门诊护理活动的重组。电子咨询的时间

Revista Espanola de Cardiologia Suplementos Pub Date : 2020-01-01 DOI: 10.1016/S1131-3587(20)30031-5

Pilar Mazón Ramos , Alejandro Virgós Lamela , José Ramón González-Juanatey

引用次数: 3